← All FR Documents
Notice

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

📖 Research Context From Federal Register API

Key Dates
Citation: 90 FR 13865
April 22-23, 2025.
Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

April 22-23, 2025.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-05241
FR Citation90 FR 13865
TypeNotice
PublishedMar 27, 2025
Effective Date-
RIN-
Docket ID-
Pages13865–13866 (2 pages)
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (277 words · ~2 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Support for Research Excellence (SuRE) Award (R16) Clinical Trial Not Allowed) and Support for Research Excellence First Independent Research (SuRE-First) Award (R16—Clinical Trial Not Allowed). <E T="03">Date:</E> April 22-23, 2025. <E T="03">Time:</E> 9:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, RML 09/9204, Hamilton, MT 59840. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Kristin L. McNally, Scientific Review Officer, Scientific Review Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, RML 09/9204, Hamilton, MT 59840. <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: March 23, 2025.</DATED> <NAME>Melanie J. Pantoja,</NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-05241 Filed 3-26-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.